White Papers

Find objective cold chain reports and get up-to-date pharma information. Download our Cold Chian, Temperature Control Logistics and related reports on Cold Chian IQ.

194 whitepaper results
of 19

Ahead of the 14th Cold Chain - GDP & Temperature Management Logistics Global Forum, Cold Chain IQ looks at the concept of global standardization with risk management in the cold chain. This whitepaper explores supply chain security and validation as they pertain to lane qualification, data monitoring, shipping lanes and stability budgets. Learn more

Tags:

Since 2012, Cold Chain IQ has acted as an international resource center for temperature control life science professionals, delivering insightful, unbiased information about the latest ‘hot topics’. Learn more

Tags:

Counterfeit pharmaceuticals can cause a lot of harm – drug recalls, loss of public confidence, law suits, and risks to patient safety. In the combat against malicious tampering, anti-counterfeiting technology aims to prevent the emergence of counterfeit drugs by creating hurdles to deter by making the task of cloning a drug too complex and expensive. Learn more

Tags:

According to a study by the Harvard Business Review, 70-90% of mergers and acquisitions fail. It’s a disconcertingly high rate – particularly when you consider that the cause cited for most failures wasn’t technological, financial or product-related. It was due to the process of the integration itself. Learn more

Tags:

Cold chains in Canada need to be especially robust due to theregion’s vast territories and extreme temperatures. On this subject, Jim Bacon Cold Chain Industry Expert (formerly withGrifols) explained: "For a moment, consider just the driving challenges encountered over the vast Canadian landscape including distance, mountain winter conditions in the west, long hauls from Ontario to Alberta around the Great Lakes, and the ferry trips to Newfoundland, to mention a few. Learn more

Even within one season, the extremes in temperature across Canada spark the need for personalized solutions within its cold chain. When a personalized cold chain solution is required, clear and well-defined criteria is of the utmost importance to allow for accurate communication with partners. Learn more

Cold Chain IQ and Pharma IQ present the top content pieces for 2015 in this annual bumper, so you can browse through some of this year’s best articles to feature on the portals. Learn more

For years, IATA has been collaborating with supply chain stakeholders to understand and define industry-wide standard requirements for temperature sensitive pharmaceutical products via air. Transporting healthcare products by air needs the establishment of complex logistical methods to maintain shipment’s integrity. It requires specific equipment, storage facilities, harmonized handling procedures and, above all, strong cooperation among the cold chain partners. Learn more

As identified by Dr. Roberto Torres (1) in a recent article, a high level of potential drugs fail to reach the market during clinical trials – which can incur large financial losses. Alongside a lack of efficacy, safety or economics, both poor planning and a failure to adequately assess the market for planning purposes are marked as key potential drivers for drug development failure. Often orchestrated on a global scale, clinical trials require the production and distribution of... Learn more

Innovation is thought to be a keystone in the process of being competitive in any market. Within clinical trial supply, a lack of innovation can be costly in regards to a range of variables. With this in mind, Pharma IQ discusses the latest trailblazing techniques in the arena with a panel of Clinical Trial Supply specialists. Learn more

194 whitepaper results
of 19